Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. [electronic resource]
- Diabetes Jul 2006
- 2042-50 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't